Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
414 studies found for:    Open Studies | "Stomach Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Comparison of SEEOX and SOX Regimens in Unresectable Gastric Cancer Patients
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: pharmorubicin;   Drug: S-1
2 Unknown  Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer
Conditions: Stomach Neoplasms;   Gastric Cancer
Intervention: Drug: mFOLFOX
3 Unknown  Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: S-1,Docetaxel
4 Unknown  Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
Condition: Stomach Neoplasms
Intervention: Drug: S-1,oxaliplatin
5 Not yet recruiting Randomized Controlled Trials Comparing Clinical Outcomes of 3D Versus 2D Laparoscopic Surgery for Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: 3D Laparoscopic Surgery;   Procedure: 2D Laparoscopic Surgery
6 Unknown  S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: S-1, capecitabine
7 Recruiting Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer
Conditions: Stomach Neoplasms;   Minimally Invasive Surgery;   Anastomosis
Interventions: Procedure: Intracorporeal Roux-en-Y esophagojejunostomy;   Procedure: Extracorporeal Roux-en-Y esophagojejunostomy
8 Not yet recruiting Randomized Controlled Trials on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Middle or Upper Third Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: D2 lymphadenectomy including No. 10;   Procedure: D2 lymphadenectomy excluding No. 10
9 Unknown  An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Taxotere, Fluorouracil, Leucovorin
10 Not yet recruiting Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Procedure: Totally laparoscopic distal gastrectomy;   Procedure: Laparoscopy-assisted distal gastrectomy
11 Recruiting 64Cu DOTA-Trastuzumab PET in Studying Patients With Gastric Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Mixed Adenocarcinoma of the Stomach;   Recurrent Gastric Cancer;   Stage IA Gastric Cancer;   Stage IB Gastric Cancer;   Stage IIA Gastric Cancer;   Stage IIB Gastric Cancer;   Stage IIIA Gastric Cancer;   Stage IIIB Gastric Cancer;   Stage IIIC Gastric Cancer
Interventions: Radiation: copper Cu 64-DOTA-trastuzumab;   Device: positron emission tomography;   Other: laboratory biomarker analysis
12 Recruiting A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer;   Gastrectomy
Intervention: Procedure: Roux-en-Y or Billroth II
13 Not yet recruiting Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer
Conditions: Gastric Tumor;   Early Gastric Cancer
Intervention:
14 Recruiting A Phase 3 Study to Compare Efficacy and Safety of DHP107 Versus Taxol® in Patients With Metastatic or Recurrent Gastric Cancer After Failure of First-line Chemotherapy
Condition: Stage IV Gastric Cancer
Intervention: Drug: Paclitaxel
15 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
16 Unknown  Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin;   Drug: tegafur-gimeracil-oteracil potassium
17 Not yet recruiting Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Capecitabine
18 Unknown  A Study of Oraxol® in Gastric Cancer Patients
Conditions: Advanced Metastatic Gastric Cancer;   Recurrent Gastric Cancer
Intervention: Drug: Paclitaxel
19 Recruiting Efficacy of Laparoscopic Subtotal Gastrectomy With D2 Lymph Node Dissection for Locally Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Procedure: Laparoscopic gastrectomy;   Procedure: Open gastrectomy
20 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years